These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1339106)

  • 21. A study of dose escalation of teniposide (VM-26) plus cisplatin (CDDP) with recombinant human granulocyte colony-stimulating factor (rhG-CSF) in patients with advanced small cell lung cancer.
    Eguchi K; Etou H; Miyachi S; Morinari H; Nakada K; Noda K; Ohkuni Y; Watanabe K; Yamada Y; Ohe Y
    Eur J Cancer; 1994; 30A(2):188-94. PubMed ID: 7512356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized trial comparing weekly versus 3-week chemotherapy in small-cell lung cancer: a Cancer Research Campaign trial.
    Souhami RL; Rudd R; Ruiz de Elvira MC; James L; Gower N; Harper PG; Tobias JS; Partridge MR; Davison AG; Trask C
    J Clin Oncol; 1994 Sep; 12(9):1806-13. PubMed ID: 8083704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New combination of the old drugs for elderly patients with small-cell lung cancer: a phase II study of the PAVE regimen.
    Westeel V; Murray N; Gelmon K; Shah A; Sheehan F; McKenzie M; Wong F; Morris J; Grafton C; Tsang V; Goddard K; Murphy K; Parsons C; Amy R; Page R
    J Clin Oncol; 1998 May; 16(5):1940-7. PubMed ID: 9586913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A threefold dose intensity treatment with ifosfamide, carboplatin, and etoposide for patients with small cell lung cancer: a randomized trial.
    Leyvraz S; Pampallona S; Martinelli G; Ploner F; Perey L; Aversa S; Peters S; Brunsvig P; Montes A; Lange A; Yilmaz U; Rosti G;
    J Natl Cancer Inst; 2008 Apr; 100(8):533-41. PubMed ID: 18398095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Small-cell lung cancer: chemotherapy strategy].
    Lebeau B
    Presse Med; 1996 Nov; 25(35):1705-8. PubMed ID: 8977583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose-intensity meta-analysis of chemotherapy regimens in small-cell carcinoma of the lung.
    Klasa RJ; Murray N; Coldman AJ
    J Clin Oncol; 1991 Mar; 9(3):499-508. PubMed ID: 1847968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pilot phase II study of hybrid chemotherapy of CAV-PVP in small cell lung cancer (SCLC)].
    Ueoka H; Ohnoshi T; Hiraki S; Kawahara S; Numata T; Nishii K; Yonei T; Yamashita H; Moritaka T; Kiura K
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2251-5. PubMed ID: 2544149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapy for small-cell lung cancer: more is not better.
    Saka H; Shimokata K
    Cancer Chemother Pharmacol; 1997; 40 Suppl():S107-9. PubMed ID: 9272144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase III study of intensive weekly chemotherapy with recombinant human granulocyte colony-stimulating factor versus standard chemotherapy in extensive-disease small-cell lung cancer. The Japan Clinical Oncology Group.
    Furuse K; Fukuoka M; Nishiwaki Y; Kurita Y; Watanabe K; Noda K; Ariyoshi Y; Tamura T; Saijo N
    J Clin Oncol; 1998 Jun; 16(6):2126-32. PubMed ID: 9626212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of granulocyte-macrophage colony-stimulating factor and dose intensification of V-ICE chemotherapy in small-cell lung cancer: a prospective randomized study of 300 patients.
    Steward WP; von Pawel J; Gatzemeier U; Woll P; Thatcher N; Koschel G; Clancy L; Verweij J; de Wit R; Pfeifer W; Fennelly J; von Eiff M; Frisch J
    J Clin Oncol; 1998 Feb; 16(2):642-50. PubMed ID: 9469353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can cytotoxic dose-intensity be increased by using granulocyte colony-stimulating factor? A randomized controlled trial of lenograstim in small-cell lung cancer.
    Woll PJ; Hodgetts J; Lomax L; Bildet F; Cour-Chabernaud V; Thatcher N
    J Clin Oncol; 1995 Mar; 13(3):652-9. PubMed ID: 7533825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intensive weekly chemotherapy for good-prognosis patients with small-cell lung cancer.
    Miles DW; Earl HM; Souhami RL; Harper PG; Rudd R; Ash CM; James L; Trask CW; Tobias JS; Spiro SG
    J Clin Oncol; 1991 Feb; 9(2):280-5. PubMed ID: 1846406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of small cell lung cancer in elderly.
    Satoh H; Ishikawa H; Funayama Y; Yamashita YT; Kamma H; Ohtsuka M; Sekizawa K
    Anticancer Res; 1999; 19(5C):4507-10. PubMed ID: 10650801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A phase I study of amrubicin combined with carboplatin for elderly patients with small-cell lung cancer.
    Inoue A; Yamazaki K; Maemondo M; Suzuki T; Kimura Y; Kanbe M; Isobe H; Nishimura M; Saijo Y; Nukiwa T
    J Thorac Oncol; 2006 Jul; 1(6):551-5. PubMed ID: 17409916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Dose-effect of chemotherapy in bronchial small-cell cancer].
    de Crevoisier R; le Cesne A; le Chevalier T
    Rev Mal Respir; 1997 Sep; 14(4):269-75. PubMed ID: 9411610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fractionated administration of irinotecan and cisplatin for treatment of extensive-disease small-cell lung cancer: a phase II study.
    Takigawa N; Fujiwara K; Ueoka H; Kiura K; Tabata M; Hiraki A; Shibayama T; Segawa Y; Kamei H; Hiraki S; Tanimoto M; Harada M
    Anticancer Res; 2003; 23(1B):557-60. PubMed ID: 12680145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Randomized systemic chemotherapy using two or three drug combination for small cell lung cancer (SCLC)].
    Eguchi K; Shimizu E; Shinkai T; Tominaga K; Saijo N; Shimabukuro Z; Shibuya M; Niitani H
    Gan No Rinsho; 1984 Feb; 30(2):115-21. PubMed ID: 6323783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). I: Survival and prognostic factors. Medical Research Council Lung Cancer Working Party.
    Bleehen NM; Girling DJ; Machin D; Stephens RJ
    Br J Cancer; 1993 Dec; 68(6):1150-6. PubMed ID: 8260367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Recent progress in chemotherapy for advanced lung cancer].
    Negoro S; Fukuoka M
    Gan To Kagaku Ryoho; 1995 Mar; 22(4):451-60. PubMed ID: 7887637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics.
    Sculier JP; Paesmans M; Lecomte J; Van Cutsem O; Lafitte JJ; Berghmans T; Koumakis G; Florin MC; Thiriaux J; Michel J; Giner V; Berchier MC; Mommen P; Ninane V; Klastersky J;
    Br J Cancer; 2001 Nov; 85(10):1444-51. PubMed ID: 11720426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.